Baoji Pharmaceutical

company

About

Baoji Pharmaceutical is a biopharma R&D manufacturer, a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production.

  • Baoshan,Shanghai,China
  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
$100M
Industries
Biopharma,Biotechnology,Medical,Pharmaceutical
Founded date
Jan 1, 2019
Number Of Employee
51 - 100
Operating Status
Active
Legal Name
Shanghai Baoji Pharmaceutical Co., Ltd.
Also Known As
Bao Pharma

Baoji Pharmaceutical is a biopharma R&D manufacturer and a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production. Baoji Pharmaceutical has established "recombinant human hyaluronidase-based subcutaneous drug delivery technology" and "pharmaceutical equipment required by assisted reproductive" as the core of its two key research and development directions. The company has established three core technology platforms, including a "medicinal enzyme engineering technology center," a "glycoprotein drug engineering technology center," and an "antibody targeting enzyme engineering technology center."

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$100M
Baoji Pharmaceutical has raised a total of $100M in funding over 2 rounds. Their latest funding was raised on Aug 25, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 25, 2022 Series B $100M 6 Oriental Fortune Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
6
Baoji Pharmaceutical is funded by 6 investors. Oriental Fortune Capital and CenterLab are the most recent investors.
Investor Name Lead Investor Funding Round
Oriental Fortune Capital Yes Series B
CenterLab Series B
Findowin Capital Series B
Haitong Innovation Capital Management Series B
Jingtong Equity Investment Series B
Sun Rock Capital Series B